A Review of Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics offers an unparalleled compilation of the current understanding of neurodegenerative disorders. This book investigates the origins of mental disorders, encompassing bacterial and fungal invasions, viral assaults, and genetic predispositions, providing readers with a thorough grasp of the neurological landscape. Each chapter dissects the intricacies of these incapacitating conditions, ranging from the pathogenesis of central nervous system tuberculosis to the involvement of endocannabinoids in…mehr
A Review of Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics offers an unparalleled compilation of the current understanding of neurodegenerative disorders. This book investigates the origins of mental disorders, encompassing bacterial and fungal invasions, viral assaults, and genetic predispositions, providing readers with a thorough grasp of the neurological landscape. Each chapter dissects the intricacies of these incapacitating conditions, ranging from the pathogenesis of central nervous system tuberculosis to the involvement of endocannabinoids in rabies infection. Topics such as neuroinflammation, axonal pathology, and the intricate relationship between diet, gut microbiomes, and cognitive decline are also explored. This book conducts an extensive examination of neurodegeneration, incorporating discussions on the role of probiotics and natural bioactive compounds in preventing ailments such as Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). With meticulous analyses of vitamins, micronutrients, antioxidants, and nutraceuticals, this work offers a roadmap for promoting neuroprotection. A Review of Diverse Neurological Disorders serves as a resource that not only reviews the current understanding but also lays the groundwork for future treatments and innovations.
1. Epidemiology and risk factors of mental disorders 2. Bacterial meningitis and neurological disorder 3. An overview on Helminthic brain infections in humans 4. Helminthic infections of the central nervous system 5. Pathogenesis and overview of central nervous system tuberculosis 6. Tuberculosis of central nervous system 7. An overview on tetanus, diphtheria, and diverse bacterial infections of the CNS 8. Tetanus, diphtheria and other bacterial infections of central nervous system 9. Pathogenesis and treatment of syphilis 10. Fungal infection of central nervous system 11. An overview on the fungal infections of the nervous system 12. Acute viral encephalitis, meningitis, and cerebral malaria 13. Neurological complications of COVID-19 infections 14. Genetic addiction risk analysis for "Preaddiction Severity Index" (PAI): A neurobiological behavioral octupus 15. Addressing the role of endocannabinoid system in rabies infection and its potential for modulation 16. Pathogenesis and Treatment of Rabies 17. An overview of pathophysiology and therapeutic approaches of Alzheimer’s disease and Parkinson’s disease 18. Ataxia and motor neuron diseases 19. Multiple system atrophy 20. Progressive supranuclear palsy 21. Epilepsy and Neurodegeneration 22. HIV/AIDS Neurological Disorders 23. Neurodegeneration and Motor Deficits 24. Neurodegeneration in autoimmune central nervous system infection 25. Inflammation and neurodegeneration in multiple sclerosis 26. Autophagy and mitophagy in amyotrophic lateral sclerosis 27. Excitation-inhibition balance in diseases of the brain: Role of NMDA and GABA receptors 28. Nutraceuticals for the prevention of stroke and cerebrovascular injury: An overview 29. HIV infection, type 1 interferons, and immune competence: Correlating brain immunity to neurodegeneration 30. Neuroinflammation: Role of adhesion molecules and signaling networks in neurovascular systems 31. Influence of Axonal Pathology in Traumatic Brain Injury 32. Axonal Pathology in Traumatic Brain Injury: An Overview 33. Ocular neurodegenerative disorders 34. Stress-associated neurodegenerative disorders: A mechanistic exploration 35. Diverse stress and neurodegeneration: An overview 36. Neurodegenerative diseases and circadian rhythm dysfunction: A bidirectional nexus 37. Advancing age, nutraceuticals, and neuroprotection 38. Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults 39. CNS drugs: Classification, characterization, and binding properties towards biomacromolecules 40. The role of gut microbiome in insomnia 41. Novel therapeutics for diverse neurological disorders 42. Elucidating the potential of natural bioactive compounds in neuroprotection 43. Vitamins, micronutrients, antioxidants, and nutraceuticals in neuroprotection: An overview 44. Olive oil and mediterranean diet: The importance of olive oil constituents, and mainly of its polyphenols, in human health - The redox system - Xenohormesis hypothesis 45. Probiotics protect against progressive deterioration of motor functions and Parkinson’s disease 46. Neuroprotective abilities of vitamins, micronutrients, antioxidants, and nutraceuticals 47. Nutraceuticals and Natural Products in the treatment of neurological disorders 48. Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders 49. The Threats and Therapeutics of Neurodegenerative Disorders: A Commentary
1. Epidemiology and risk factors of mental disorders 2. Bacterial meningitis and neurological disorder 3. An overview on Helminthic brain infections in humans 4. Helminthic infections of the central nervous system 5. Pathogenesis and overview of central nervous system tuberculosis 6. Tuberculosis of central nervous system 7. An overview on tetanus, diphtheria, and diverse bacterial infections of the CNS 8. Tetanus, diphtheria and other bacterial infections of central nervous system 9. Pathogenesis and treatment of syphilis 10. Fungal infection of central nervous system 11. An overview on the fungal infections of the nervous system 12. Acute viral encephalitis, meningitis, and cerebral malaria 13. Neurological complications of COVID-19 infections 14. Genetic addiction risk analysis for "Preaddiction Severity Index" (PAI): A neurobiological behavioral octupus 15. Addressing the role of endocannabinoid system in rabies infection and its potential for modulation 16. Pathogenesis and Treatment of Rabies 17. An overview of pathophysiology and therapeutic approaches of Alzheimer’s disease and Parkinson’s disease 18. Ataxia and motor neuron diseases 19. Multiple system atrophy 20. Progressive supranuclear palsy 21. Epilepsy and Neurodegeneration 22. HIV/AIDS Neurological Disorders 23. Neurodegeneration and Motor Deficits 24. Neurodegeneration in autoimmune central nervous system infection 25. Inflammation and neurodegeneration in multiple sclerosis 26. Autophagy and mitophagy in amyotrophic lateral sclerosis 27. Excitation-inhibition balance in diseases of the brain: Role of NMDA and GABA receptors 28. Nutraceuticals for the prevention of stroke and cerebrovascular injury: An overview 29. HIV infection, type 1 interferons, and immune competence: Correlating brain immunity to neurodegeneration 30. Neuroinflammation: Role of adhesion molecules and signaling networks in neurovascular systems 31. Influence of Axonal Pathology in Traumatic Brain Injury 32. Axonal Pathology in Traumatic Brain Injury: An Overview 33. Ocular neurodegenerative disorders 34. Stress-associated neurodegenerative disorders: A mechanistic exploration 35. Diverse stress and neurodegeneration: An overview 36. Neurodegenerative diseases and circadian rhythm dysfunction: A bidirectional nexus 37. Advancing age, nutraceuticals, and neuroprotection 38. Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults 39. CNS drugs: Classification, characterization, and binding properties towards biomacromolecules 40. The role of gut microbiome in insomnia 41. Novel therapeutics for diverse neurological disorders 42. Elucidating the potential of natural bioactive compounds in neuroprotection 43. Vitamins, micronutrients, antioxidants, and nutraceuticals in neuroprotection: An overview 44. Olive oil and mediterranean diet: The importance of olive oil constituents, and mainly of its polyphenols, in human health - The redox system - Xenohormesis hypothesis 45. Probiotics protect against progressive deterioration of motor functions and Parkinson’s disease 46. Neuroprotective abilities of vitamins, micronutrients, antioxidants, and nutraceuticals 47. Nutraceuticals and Natural Products in the treatment of neurological disorders 48. Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders 49. The Threats and Therapeutics of Neurodegenerative Disorders: A Commentary
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309